MCCORMICK & CO INC MKC
NYSE · stock · Miscellaneous Food Preparations & Kindred Products · website · IPO 1980-03-17
MCCORMICK & CO INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8B | $6.7B | $6.7B | $6.4B | $6.3B | $5.6B | $5.3B | $5.3B | $4.8B | $4.4B |
| Gross profit | $2.6B | $2.6B | $2.5B | $2.3B | $2.5B | $2.3B | $2.1B | $2.1B | $1.8B | $1.8B |
| R&D expense | $106.1M | $102.9M | $94.9M | $87.5M | $87.3M | $68.6M | $67.3M | $69.4M | $66.1M | $61.0M |
| SG&A expense | $1.5B | $1.5B | $1.5B | $1.4B | $1.4B | $1.3B | $1.2B | $1.2B | $1.0B | $1.2B |
| Operating income | $1.1B | $1.1B | $963.0M | $863.6M | $1.0B | $999.5M | $957.7M | $891.1M | $699.8M | $641.0M |
| Interest expense | $196.2M | $209.4M | $208.2M | $149.1M | $136.6M | $135.6M | $165.2M | $174.6M | $95.7M | $56.0M |
| Income tax | $195.8M | $184.0M | $174.5M | $168.6M | $192.7M | $174.9M | $157.4M | -$157.3M | $151.3M | $153.0M |
| Net income | $789.4M | $788.5M | $680.6M | $682.0M | $755.3M | $747.4M | $702.7M | $933.4M | $477.4M | $472.3M |
| EPS (diluted) | $2.93 | $2.92 | $2.52 | $2.52 | $2.80 | $2.78 | $2.62 | $3.50 | $1.86 | $1.84 |
| Operating cash flow | $962.2M | $921.9M | $1.2B | $651.5M | $828.3M | $1.0B | $946.8M | $821.2M | $815.3M | $658.1M |
| Free cash flow | — | — | — | $389.5M | $550.3M | $816.0M | $773.1M | $652.1M | $632.9M | $504.3M |
| Cash & equivalents | $95.9M | $186.1M | $166.6M | $334.0M | $351.7M | $423.6M | $155.4M | $96.6M | $186.8M | $118.4M |
| Inventory | $1.3B | $1.2B | $1.1B | $1.3B | $1.2B | $1.0B | $801.2M | $786.3M | $793.3M | $756.3M |
| Total assets | $13.2B | $13.1B | $12.9B | $13.1B | $12.9B | $12.1B | $10.4B | $10.3B | $10.4B | $4.6B |
| Total liabilities | $7.4B | $7.8B | $7.8B | $8.4B | $8.5B | $8.1B | $6.9B | $7.1B | $7.8B | $3.0B |
| Shareholders' equity | $5.8B | $5.3B | $5.1B | $4.7B | $4.4B | $3.9B | $3.5B | $3.2B | $2.6B | $1.6B |
Growth · year-over-year · Revenue CAGR 5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1.7% | +0.9% | +4.9% | +0.5% | +12.8% | +4.7% | +0.8% | +9.7% | +9.6% | +2.7% |
| Net income growth | +0.1% | +15.9% | -0.2% | -9.7% | +1.1% | +6.4% | -24.7% | +95.5% | +1.1% | +17.6% |
| EPS growth | +0.3% | +15.9% | +0.0% | -10.0% | +0.7% | +6.1% | -25.1% | +88.2% | +0.8% | +18.6% |
| Free cash flow growth | — | — | — | -29.2% | -32.6% | +5.5% | +18.6% | +3.0% | +25.5% | +9.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-11-30. Facts plus Stocktoria's own computed scores — not investment advice.